Year partnered with Savant: 2022
Sector: Med-tech
Application: Novel Ophthalmology
Product: Patented glaucoma stent leverages natural anatomical mechanisms for clinically effective and cost-saving solution
Market Size: (Local) ZAR 18.63 billion (Global) USD 800 million
Differentiation: Patented enhancements in Continuously Stirred Tank Reactor (CSTR) technology
Investment Stage: Pre-Seed
Stage: Venture and Grow Locally
Founding Team: Daemon McClunan